Orthofix Q2 FY26 net loss widens to USD 15.8 million; net sales rise 4% to USD 210.9 million

Reuters2026/08/05 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Orthofix posted Q2 net sales of USD 210.9 million, up 4% from a year earlier.
Net loss widened to USD 15.8 million, or USD 0.39 a share.
Non-GAAP adjusted EBITDA edged down to USD 20.1 million, from USD 20.6 million.
Cash, cash equivalents and restricted cash fell to USD 104.4 million, due to arbitration award and settlement payments.
Raised 2026 net sales outlook to USD 845 million-USD 855 million; lifted non-GAAP adjusted EBITDA view to USD 95 million-USD 98 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orthofix Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260805908825) on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Orthofix Q2 FY26 net loss widens to USD 15.8 million; net sales rise 4% to USD 210.9 million

You may also like

Crypto prices